MedPath

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms

Completed
Conditions
Asthma
Registration Number
NCT00986219
Lead Sponsor
AstraZeneca
Brief Summary

The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
696
Inclusion Criteria
  • Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time
Exclusion Criteria
  • Patient with a cardiac disease (congestive heart failure, coronary heart disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthmaDay 1
Secondary Outcome Measures
NameTimeMethod
The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities.Day 1
The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ).Day 1
The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms.Day 1

Trial Locations

Locations (1)

Research Site

🇬🇷

Lakonia, Greece

© Copyright 2025. All Rights Reserved by MedPath